共 50 条
- [31] Gleevec™ for the treatment of chronic myelogenous leukemia:: US food and drug administration regulatory mechanisms, accelerated approval, and orphan drug statusONCOLOGIST, 2002, 7 (05): : 390 - 392Cohen, MHMoses, MLPazdur, R
- [33] US Food and Drug Administration Approval Overview in Metastatic Breast CancerJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1705 - 1711Cortazar, PatriciaJustice, RobertJohnson, JohnSridhara, RajeshwariKeegan, PatriciaPazdur, Richard
- [34] Efficacy Considerations for US Food and Drug Administration Approval of Diagnostic RadiopharmaceuticalsJOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) : 1479 - 1484Gorovets, AlexanderMarzella, LouisRieves, DwaineYang, Lucie
- [35] Concerns About the Approval of Nusinersen Sodium by the US Food and Drug AdministrationJAMA INTERNAL MEDICINE, 2018, 178 (06) : 743 - 744Gerrity, Martha S.Prasad, VinayObley, Adam J.
- [38] Novartis faces first hitch in the US Food and Drug Administration approvalChemistry and Industry (London), 2001, (13):Anon
- [39] Time for the US food and drug administration approval of condoms for anal intercourseECLINICALMEDICINE, 2019, 17Nguyen, Brian T.Nelson, Anita L.
- [40] Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated ApprovalMILBANK QUARTERLY, 2017, 95 (02): : 261 - 290Naci, HuseyinWouters, Olivier J.Gupta, RadhikaIoannidis, John P. A.